Completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) NCT05461430 Conditions Adenocarcinoma, Adenoma, Adnexal Diseases, +139 more Locations xCures — Oakland, California, United States View Trial Details
Completed Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies NCT01306045 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma NCT04321330 Conditions Carcinoma, Thymic, Hemic and Lymphatic Diseases, Lymphatic Diseases, +7 more Locations Sichuan Cancer Hospital — Chengdu, China West China Hospital, Sichuan University; Department of Breast — Chengdu, China The Second Affiliated Hospital, Chongqing Medical University — Chongqing, China Fujian Medical University Union Hospital — Fuzhou, China View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers NCT05544929 Conditions Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more Locations Massachusetts General Hospital . — Boston, Massachusetts, United States Massachusetts General Hospital — Boston, Massachusetts, United States NYU School of Medicine — New York, United States University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States View all 19 locations View more locations Show fewer locations Loading locations... View Trial Details
